九洲药业 (603456)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameZhejiang Jiuzhou Pharmaceutical Co., Ltd.
Listing Date2014-10-10
Issue Price15.43RMB
Registered Capital88944.602810k RMB
Legal RepresentativeHua Lirong
Registered AddressWaisha Industrial Zone, Jiaojiang District, Taizhou City, Zhejiang Province
IndustryMedical Services
Main BusinessProvides CDMO one-stop services for the R&D and production of innovative drugs for large and medium-sized pharmaceutical enterprises at home and abroad. Simultaneously offers process technology innovation and commercial production services for chemical active pharmaceutical ingredients (APIs) and pharmaceutical intermediates to global clients.
Company ProfileThe company is a listed pharmaceutical enterprise primarily engaged in specialty active pharmaceutical ingredients (APIs) and providing CDMO one-stop services for new drugs to major international pharmaceutical companies. It is a leading global manufacturer of APIs for Carbamazepine, Oxcarbazepine, Ketoprofen, and Gliclazide, with its international market share ranking among the top globally. The company has received numerous honors, including National Top 100 Pharmaceutical Enterprise, National Leading API Export Enterprise, National High-Tech Enterprise, National Technology Innovation Demonstration Enterprise, China's Top 100 Pharmaceutical Manufacturers, Zhejiang Province's 'Three Names' (Famous Brand, Famous Enterprise, Famous Product) Cultivation Pilot Enterprise, and Zhejiang Province Innovative Leading Enterprise. The 'Jiuzhou' brand has been awarded 'Zhejiang Province Export Famous Brand'.
Stock Details
1. Key Indicators
- Total Shares(W): 88944.60
- Circulating A-Shares(W): 88944.60
- Earnings Per Share(RMB): 0.8400
- Net Assets Per Share(RMB): 9.8434
- Operating Revenue(W RMB): 416048.77
- Total Profit(W RMB): 90980.74
- **Net Profit Attributable to Parent(W RMB) **: 74765.28
- Net Profit Growth Rate(%): 18.51
- Weighted Return on Equity(%): 8.5700
- Operating Cash Flow Per Share(RMB): 1.5090
- Undistributed Profit Per Share(RMB): 3.7543
- Capital Reserve Per Share(RMB): 4.8181
2. Main Business
The main business covers:
- Providing CDMO one-stop services for innovative drugs in R&D and production to large and medium-sized pharmaceutical enterprises at home and abroad
3. Company Basic Information
- Company Name: Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
- Listing Date: 2014-10-10
- Industry: Pharmaceutical Manufacturing
- Address: No. 99 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
- Website: https://www.jiuzhoupharma.com/
- Company Profile: The issuer was approved by the Securities Committee of Zhejiang Provincial People's Government on June 5, 1998 with the document "Approval on the Establishment of Zhejiang Jiuzhou Pharmaceutical Co., Ltd." (Zhe Zheng Wei [1998] No. 60), and was established as a joint stock limited company by five legal entities including Zhongbei Group, Qiongshan Wangda, Huangyan Jiuhua, Yizhou Chemical, and Siwei Chemical through the promotion method. Among them, Zhongbei Group contributed 23 million yuan from its assessed net asset value; Qiongshan Wangda contributed 1.5 million yuan in cash; Yizhou Chemical and Siwei Chemical each contributed 500,000 yuan in cash; Huangyan Jiuhua contributed 500,000 yuan in cash and 500,000 yuan owed to it by Zhongbei Group. On July 13, 1998, the company was registered with the Zhejiang Provincial Administration for Industry and Commerce and obtained the business license of enterprise legal person. The legal representative was Hua Xuande, the registered capital was 26.5 million yuan, the enterprise type was a joint stock limited company, and the business term was perpetual.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Zhongbei Jiuzhou Group Co., Ltd. | General Legal Person | 28351.88 | 31.88 |
| 2 | Taizhou City Gede Industrial Co., Ltd. | General Legal Person | 4058.57 | 4.56 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2036.80 | 2.29 |
| 4 | China Europe Healthcare Hybrid Securities Investment Fund Class A | Fund | 1740.30 | 1.96 |
| 5 | Huabao China Securities Medical ETF | Fund | 1522.25 | 1.71 |
| 6 | National Social Security Fund 502 Portfolio | Social Security Fund | 1269.99 | 1.43 |
| 7 | Xinda Healthy China Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 98.64 | 0.11 |
| 8 | Morgan Stanley Youyue Anhe Hybrid Securities Investment Fund Class A | Fund | 12.91 | 0.01 |
| 9 | Harvest New Additive Regular Open Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 2.26 | 0.00 |
5. Concept Sectors
- Artificial Intelligence
- CXO Concept
- Innovative Drugs
- Synthetic Biology
- DeepSeek
- AI Healthcare
- Margin Trading
- High-Performance Stocks
- Intensive Research
- Overseas Business
- SSE Governance
- SSE 380
- Small Cap Growth
- Small Cap Value
- SZSE Growth
- SZSE Value
Remarks
- Data update date: 2025-11-01
- Data source: Public market information